antibody-drug conjugation

Seagen, Nurix Therapeutics, Collaboration, ADC Technologies, antibody-drug conjugation, targeted protein degradation

Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies

Anika Sharma

Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...